NDC11 73043002201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73043-0022-01 | 73043-0022 |
| 73043-0022-1 | 73043-0022 |
| 73043-022-01 | 73043-022 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | Devatis Inc. | c90bcb14-eb8d-4753-b339-3469c664ecd2 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | 73043-022-01 73043-022 73043002201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.